Literature DB >> 25456879

Predictors of natriuretic peptide non-response in patients hospitalized with acute heart failure.

Ana Ribeiro1, Patrícia Lourenço2, Sérgio Silva3, Francisco Cunha4, João Vilaça4, Filipa Gomes4, José Paulo Araújo2, Paulo Bettencourt2.   

Abstract

Increasing natriuretic peptide (NP) levels are associated with worse heart failure (HF) outcomes. Predictors of NP nonresponse have not been studied. The aim of this study was to identify predictors of nondecreasing NP levels during episodes of acute HF. A retrospective analysis was conducted in patients prospectively included in a registry of acute HF, with the primary diagnosis of acute HF. The objective under analysis was B-type NP (BNP) response, defined as a >30% decrease in BNP during hospitalization. Percentage of BNP variation was calculated as: % BNP variation = [(admission BNP - discharge BNP)/admission BNP] × 100. A logistic regression analysis was performed to study potential predictors of NP nonresponse. A multivariate model was built. A total of 496 patients were studied: 28.2% were considered nonresponders to the implemented HF treatment strategy. Identified predictors of nonresponse were older age, chronic HF, lower admission systolic blood pressure, anemia, renal dysfunction, and lower sodium on admission, as well as lower admission albumin and lower admission total cholesterol. Admission BNP was not a predictor of response. The only identified independent predictor of nonresponse was a low admission total cholesterol level (cutoff 125 mg/dl), with an odds ratio of 2.55 (95% confidence interval 1.59 to 4.11). This remained valid when the analysis was stratified according to admission BNP (cutoff 2,000 pg/ml) and according to statin use. In conclusion, a low admission total cholesterol level was a strong and independent predictor of BNP nonresponse in patients admitted with acute HF. The ability of cholesterol to predict BNP nonresponse was valid for patients with intrinsically low cholesterol and in those with statin-induced low cholesterol.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25456879     DOI: 10.1016/j.amjcard.2014.09.053

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  4 in total

1.  Impact of N-terminal pro-B-type natriuretic peptide response on long-term prognosis after transcatheter aortic valve implantation for severe aortic stenosis and heart failure.

Authors:  Hidehiro Kaneko; Frank Hoelschermann; Grit Tambor; Maki Okamoto; Michael Neuss; Christian Butter
Journal:  Heart Vessels       Date:  2018-11-15       Impact factor: 2.037

2.  THE ROLE OF NT PRO-BNP IN THE EVALUATION OF DIABETIC PATIENTS WITH HEART FAILURE.

Authors:  F I Fringu; A V Sitar-Taut; B Caloian; D Zdrenghea; D Comsa; G Gusetu; D Pop
Journal:  Acta Endocrinol (Buchar)       Date:  2020 Apr-Jun       Impact factor: 0.877

3.  Association Between Cardiac Natriuretic Peptides and Lipid Profile: a Systematic Review and Meta-Analysis.

Authors:  Francesco Spannella; Federico Giulietti; Marica Bordicchia; John C Burnett; Riccardo Sarzani
Journal:  Sci Rep       Date:  2019-12-16       Impact factor: 4.379

4.  Periprocedural changes in natriuretic peptide levels and clinical outcome after transcatheter mitral valve repair.

Authors:  Tetsu Tanaka; Refik Kavsur; Maximilian Spieker; Christos Iliadis; Clemens Metze; Patrick Horn; Atsushi Sugiura; Malte Kelm; Stephan Baldus; Georg Nickenig; Ralf Westenfeld; Roman Pfister; Marc Ulrich Becher
Journal:  ESC Heart Fail       Date:  2021-09-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.